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Despite efforts to improve the statistical quality of research articles in medical journals, serious 
statistical errors or deficiencies in the design, analysis, reporting and interpretation still occur, even 
in highly-ranked journals1. Flawed statistics and methodology will negatively affect the study 
results and could consequently impact public health and patient care2. Despite numerous 
descriptive papers on biostatistics as well as reporting guidelines including CONSORT, STROBE, 
STARD, REMARK and TRIPOD (and others as listed in the EQUATOR Network; www.equator-
network.org) endorsed by many journals3-7, the methodological quality of medical publications 
still remains low8 9. Editors and reviewers may not have expert knowledge of statistics, and worse, 
could remain unconvinced about the importance of solid methodology in medical research10. Thus, 
a systematic approach to assess the methodological or statistical aspects of a scientific paper is 
needed.  
Introducing the CHAMP statement 
Although there are some excellent guidelines on reporting statistics in medical papers11-14, and 
further direction available from a small number of journals, a checklist for peer reviewers (and 
readers) to use to assess general statistical aspects in a research publication is lacking. In this paper, 
we present CHAMP, a CHecklist for statistical Assessment of Medical Papers (Table 1) which 
contains 30 items on general statistical aspects to assess during peer review of original papers. The 
checklist includes considerations in the following sections: design and conduct (items 1-6), data 
analysis (items 7-16), reporting and presentation (items 17-23), and interpretation (items 24-30). 
A complete explanation and elaboration of the 30 item checklist with glossary of statistical terms 
is provided (see Appendix). The items in the checklist were selected based on a previous 
BMJ checklist15, literature review, and experience of the author panel in reviewing the statistical 
content of numerous papers submitted to a variety of medical journals. The first author produced 
the checklist draft, the coauthors suggested addition or removal of the items, and all authors 
approved the final version. Other colleagues provided extensive comments on the paper and are 
listed in the Acknowledgments. 
CHAMP does not cover all topics of medical statistics but focuses on important and common 
statistical issues that may generally arise. We appreciate that each type of study or statistical model 
such as a randomized trial or prediction model has specific issues which may not be covered in 
our checklist. We also note that for some items in the checklist there may be no decisive answer, 
and thus assessment of the methodology of a paper may involve some subjectivity. Moreover, the 
issues raised in the checklist are not equally important – e.g., serious errors in design are 
irremediable regardless of how the data were analyzed, and problems of presentation are less 
important (as these can be easily fixed) than other statistical problems.  
Applying CHAMP during peer-review 
Using CHAMP requires some elementary knowledge of statistics, as is also needed for the authors 
of scientific manuscripts16. Further guidance on how to use the checklist can be found in the 
companion Explanation and Elaboration paper (see Appendix)17. Each item of the checklist is a 
reminder for the reviewer in formulating an overall assessment of the statistical analysis of the 
paper, and perhaps in providing clarifying comments and revision requests to the authors. Future 
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study of the CHAMP statement is needed to examine its utility and possibly establish a point 
system for rating the appropriateness of the statistical and methodological aspects of an original 
investigation.  
In the interim, we hope CHAMP provides a useful tool in the editorial process for editors and 






Design and conduct  
1. Clear description of the goal of research, study objective(s), study 
design, and study population 
Yes Unclear No 
2. Clear descriptions of outcomes, exposures/treatments and 
covariates, and their measurement methods 
Yes Unclear No 
3. Validity of study design Yes Unclear No 
4. Clear statement and justification of sample size Yes Unclear No 
5. Clear declaration of design violations and acceptability of the 
design violations  
Yes Unclear No 
6. Consistency between the paper and its previously published 
protocol 
Yes Unclear No 
Data analysis     
7. Correct and complete description of statistical methods Yes Unclear No 
8. Valid statistical methods used and   assumptions outlined Yes Unclear No 
9. Appropriate assessment of treatment effect or interaction between 
treatment and another covariate 
Yes Unclear No 
10. Correct use of correlation and associational statistical testing  Yes Unclear No 
11. Appropriate handling of continuous predictors  Yes Unclear No 
12. Confidence intervals do not include impossible values Yes Unclear No 
13. Appropriate comparison of baseline characteristics between the 
study arms in randomized trials  
Yes Unclear No 
14. Correct assessment and adjustment of confounding  Yes Unclear No 
15. On-support inference i.e., no model extrapolation to the region not 
supported by data 
Yes Unclear No 
16. Adequate handling of missing data Yes Unclear No 
Reporting and presentation    
17. Adequate and correct description of the data Yes Unclear No 
18. Descriptive results provided as occurrence measures with 
confidence intervals, and analytic results provided as association 
measures and confidence intervals along with P-values 
Yes Unclear No 
19. Confidence intervals provided for the contrast between groups 
rather than for each group  
Yes Unclear No 
20. Avoiding selective reporting of analyses and P-hacking Yes Unclear No 
21. Appropriate and consistent numerical precisions for effect sizes, 
test statistics, and P-values, and reporting the P-values rather their 
range 
Yes Unclear No 
22. Providing sufficient numerical results that could be included in a 
subsequent meta-analysis  
Yes Unclear No 
23. Acceptable presentation of the figures and tables  Yes Unclear No 
Interpretation    
24. Interpreting the results based on association measures and 95% 
confidence intervals along with P-values, and correctly interpreting 
large P-values as indecisive results, not evidence of absence of an 
effect  
Yes Unclear No 
25. Using confidence intervals rather than post-hoc power analysis for 
interpreting the results of studies 
Yes Unclear No 
26. Correctly interpreting occurrence or association measures Yes Unclear No 
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27. Distinguishing causation from association and correlation  Yes Unclear No 
28. Results of pre-specified analyses are distinguished from the results 
of exploratory analyses in the interpretation 
Yes Unclear No 
29. Appropriate discussion of the study methodological limitations Yes Unclear No 
30. Drawing only conclusions supported by the statistical analysis and 
no generalization of the results to subjects outside the target 
population 
Yes Unclear No 
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